Atlas Trials

Safety and Immunogenicity of a Candidate MERS-CoV Vaccine (MERS001)

Clinical trial NCT03399578 · TERMINATED

Trial details

NCT number
NCT03399578
Sponsor
University of Oxford
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
MERS (Middle East Respiratory Syndrome)
Start date
2018-03-14
Primary completion
2021-09-17
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.